IBIO vs ANRO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

IBIO

47.7
AI Score
VS
IBIO Wins

ANRO

43.4
AI Score

Investment Advisor Scores

IBIO

48score
Recommendation
HOLD

ANRO

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IBIO ANRO Winner
Net Income -18.38M -53.88M IBIO
Operating Income -18.60M -56.27M IBIO
ROE -123.5% -24.6% ANRO
ROA -79.3% -21.2% ANRO
Total Assets 23.18M 254.07M ANRO
Cash 8.58M 243.73M ANRO
Current Ratio 1.59 14.85 ANRO
Free Cash Flow -15.32M -47.41M IBIO

Relative Price Performance (Last 90 Days)

IBIO 1M: -1.4% · 3M: -23.4% ANRO 1M: +30.9% · 3M: +65.2%

Current Technical Phase

IBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.7 · Price: $1.41

ANRO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (16.7% over 20 days), RSI 75

RSI (14): 74.6 · Price: $35.05

Fundamentals Snapshot

Metric IBIO ANRO
Market Cap
Forward P/E -4.6 -17.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 1.0%
Operating Margin -96.5% 0.0%
EPS -0.55 -2.32
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IBIO is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.